Appendix A
Workshop Agenda

THE UNIVERSITY-INDUSTRY INTERFACE AND MEDICAL INNOVATION

Sunday, February 21, 1993

2:30 p.m.

Welcome

Kenneth Shine, President, Institute of Medicine;

Introduction to the Workshop

Enriqueta Bond, Executive Officer, Institute of Medicine

Session I. Setting The Stage

Moderator:

Ken Melmon, Stanford University

Some Further Thoughts on the Origin of the Workshop

3:00

Medical Innovation and the Economic Environment

Victor Fuchs, Stanford University

3:30

R&D Management: An Academic Perspective

Stanley Cohen, Stanford University

4:00

Institutional Factors Affecting the University-Industry Interface

Niels Reimers, Technology Linkages International

4:30

Discussion



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 223
Sources of Medical Technology: Universities and Industry Appendix A Workshop Agenda THE UNIVERSITY-INDUSTRY INTERFACE AND MEDICAL INNOVATION Sunday, February 21, 1993 2:30 p.m. Welcome Kenneth Shine, President, Institute of Medicine; Introduction to the Workshop Enriqueta Bond, Executive Officer, Institute of Medicine Session I. Setting The Stage Moderator: Ken Melmon, Stanford University Some Further Thoughts on the Origin of the Workshop 3:00 Medical Innovation and the Economic Environment Victor Fuchs, Stanford University 3:30 R&D Management: An Academic Perspective Stanley Cohen, Stanford University 4:00 Institutional Factors Affecting the University-Industry Interface Niels Reimers, Technology Linkages International 4:30 Discussion

OCR for page 223
Sources of Medical Technology: Universities and Industry 5:00 R&D Management: An Industrial Perspective Alejandro Zaffaroni, ALZA Corporation 5:30 The Evolution of Biotechnology Drugs at AMGEN and ICOS George Rathmann, ICOS Respondent: Joel Birnbaum, Hewlett-Packard 6:00 Discussion 7:00 Adjourn and Dinner Monday, February 22, 1993 8:15 a.m. Continental Breakfast Session II. Medical Device Innovation Moderator: Bill Hubbard, Former President, The Upjohn Company Respondents: Ben Holmes, Hewlett-Packard; James Benson, Health Industry Manufacturers Association; and Harvey Rudolph, Food and Drug Administration 8:45 Minimally Invasive Therapy: The Case of Endoscopy Introduction: Nathan Rosenberg, Stanford University, and Annetine Gelijns, Institute of Medicine/Columbia University Discussion 9:45 The Laser in Medicine: Birth of a New Industry Introduction: Joanne Spetz, Stanford University Discussion 10:45 Break 11:00 Cardiovascular Diagnostics Introduction: Stan Finkelstein, Massachusetts Institute of Technology, Gregory Bell, Charles River Associates, and Kevin Neels, Quintiles Discussion

OCR for page 223
Sources of Medical Technology: Universities and Industry 12:00 Medical Imaging: MRI and PET Introduction: Richard Rettig, Institute of Medicine, Holly Dawkins, Institute of Medicine, and Everette James, Vanderbilt University Discussion 1:00 Lunch 2:15 Cochlear Implants Introduction: Stuart Blume, University of Amsterdam Discussion Session III. Pharmaceutical And Biotech Innovation Moderator: Stanley Reiser, University of Texas Health Science Center Respondents: Gerald Laubach, Former President, Pfizer; Rebecca Henderson, Massachusetts Institute of Technology; James Benson, Health Industry Manufacturers Association 3:15 Purine Metabolism and the Development of Chemotherapeutic Agents Introduction: Chris Flowers and Ken Melmon, Stanford University Discussion 4:15 Break 4:30 Innovation in Biotechnology: The Case of the Small Firm Introduction: Alfonso Gambardella, Bocconi University, Milan, and Ashish Arora, Carnegie-Mellon University Discussion 5:30 Adjournment

OCR for page 223
Sources of Medical Technology: Universities and Industry Tuesday, February 23, 1993 Session III. Pharmaceutical And Biotech Innovation (continued) Moderator: Stanley Reiser, University of Texas Health Science Center Respondents: Gerald Laubach, Former President, Pfizer; Rebecca Henderson, Massachusetts Institute of Technology; James Benson, Health Industry Manufacturers Association 8:00 a.m. Innovation in Compounds to Treat Diabetes Introduction: Scott Stern, Stanford University Discussion 9:00 What Is Public? What Is Private? And What Should Be? Richard Nelson, Columbia University Discussion 9:30 General Discussion 10:00 Break 10:30 Where Do We Go From Here? Ken Melmon, Stanford University Richard Nelson, Columbia University Nathan Rosenberg, Stanford University 11:00 Adjournment